Related Experiment Video
Updated: Oct 15, 2025

10:31
Robust Differentiation of Human iPSCs into a Pure Population of Adipocytes to Study Adipocyte-Associated Disorders
Published on: February 9, 2022
3.7K
Stem Cell Research Tools in Human Metabolic Disorders: An Overview
Serena Ricci1, Pietro Cacialli2
1Department of Cell Physiology and Metabolism, School of Medicine, University of Geneva, Rue Michel Servet 1, 1206 Geneva, Switzerland.
Cells
|October 23, 2021
Summary
Stem cell and gene therapies show promise for treating metabolic disorders like diabetes and lysosomal storage diseases. Overcoming clinical hurdles is key to making these advanced treatments widely available.
Area of Science:
- Regenerative Medicine
- Metabolic Disease Research
- Genetic Therapy
Background:
- Metabolic disorders represent a significant global health burden with high healthcare costs.
- Current treatments for many metabolic disorders are limited, necessitating novel therapeutic strategies.
- Inherited and acquired metabolic conditions pose substantial societal and economic challenges.
Purpose of the Study:
- To review recent advancements in stem cell and gene therapy for metabolic disorders.
- To highlight promising clinical results in human patients.
- To identify critical challenges hindering the translation of these therapies to clinical practice.
Main Methods:
- Literature review of stem cell and gene therapy research.
- Analysis of clinical trial data and patient outcomes.
- Discussion of translational barriers in regenerative medicine.
Main Results:
- Stem cell and gene therapies demonstrate potential for long-term treatment of metabolic diseases.
- Promising results observed in human patients with inherited (e.g., lysosomal storage diseases) and acquired (e.g., diabetes mellitus, obesity) conditions.
- Significant progress has been made, but challenges remain for widespread clinical application.
Conclusions:
- Stem cell and gene therapies offer a promising future for managing metabolic disorders.
- Further research and development are needed to overcome existing hurdles.
- Successful translation from bench to clinic could revolutionize metabolic disease treatment.
Related Concept Videos
EPS and iPS Cells in Disease Research
3.0K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.0K
Stem Cell Culture
5.6K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.6K
Embryonic Stem Cells
4.0K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.0K

